« Back to Record
Citation APA

Bourgeois, S., Francque, S., Vijgen, L., Kakuda, T. T., Hoeben, E., Luo, D., Vandebosch, A., Jacquemyn, B., Van Remoortere, P., Verloes, R., Van Vlierberghe, H., Moreno, C., Orlent, H., Nevens, F., Arasteh, K., Horsmans, Y., Schattenberg, J. M., & Buggisch, P. (2017). Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection. BMC gastroenterology, 17(1), 26. doi:10.1186/s12876-017-0580-2


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/247807

Bourgeois, S., Francque, S., Vijgen, L., Kakuda, T. T., Hoeben, E., Luo, D., Vandebosch, A., Jacquemyn, B., Van Remoortere, P., Verloes, R., Van Vlierberghe, H., Moreno, C., Orlent, H., Nevens, F., Arasteh, K., Horsmans, Y., Schattenberg, J. M., & Buggisch, P. (2017). Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection. BMC gastroenterology, 17(1), 26. doi:10.1186/s12876-017-0580-2